Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed944b103dff3e7217cb75e5f6ab0842 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6324cb1176d069e635680eeccb37859c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76ab710b1d26d786dd39188021f03a3b |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-143 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-665 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-665 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
filingDate |
2011-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3c3e51909165255a91d8492a7adeba6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34b79c5c997436b62cf4c801d4cb35ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cc67e260222415f487c4097ec421078 |
publicationDate |
2013-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2013164336-A1 |
titleOfInvention |
Antimicrobial and anti-inflammatory action pharmaceutical composition for parenteral administration and its production process |
abstract |
There is proposed herein a process for production of composite antimicrobial preparations for parenteral administration, featuring a higher therapeutic efficiency in case of grave infection and inflammatory diseases. The proposed compositions include an active agent being fosfomycin and finely dispersed nanostructured silica dioxide, with a weight ratio from 10:1 to 75:1 respectively. The mentioned production process includes mixing fosfomycin with finely dispersed nanostructured silica dioxide. Its main difference is that the mixture of aforementioned substances with the mentioned weight ratio is exposed to mechanical processing by blow impact and abrasive actions until a portion of the fine powder fraction with particles smaller than 5 micrometers, contained in the mixture, increases to at least 25%. The so obtained mixture is used for injection preparations. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9844566-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015283172-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9889158-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014105936-A1 |
priorityDate |
2010-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |